Why Are Corticosteroids Dangerous in Scleroderma?
At a Glance
High-dose oral or intravenous corticosteroids, like prednisone, are dangerous for systemic sclerosis patients because they can trigger Scleroderma Renal Crisis. This is a severe, life-threatening medical emergency causing rapid kidney failure and dangerous spikes in blood pressure.
In this answer
3 sections
Your rheumatologist has likely warned you to avoid high-dose oral or intravenous corticosteroids (like prednisone, methylprednisolone, or dexamethasone) because they are a major trigger for a life-threatening medical emergency known as Scleroderma Renal Crisis (SRC) [1][2]. While these medications are frequently and safely prescribed to the general public for common ailments like poison ivy, acute bronchitis, or sinus infections, taking them can cause rapid, catastrophic damage to your kidneys if you have systemic sclerosis (scleroderma) [3][4][5].
(Note: This warning specifically applies to systemic steroids—those taken as pills or through an IV [2][3]. Localized steroids, such as over-the-counter hydrocortisone creams for rashes or steroid inhalers for asthma, do not carry this same severe risk because they are not absorbed into your bloodstream at high levels.)
What is Scleroderma Renal Crisis (SRC)?
Scleroderma Renal Crisis (SRC) is a severe and abrupt complication of systemic sclerosis characterized by rapid kidney failure and, in most cases, dangerously high blood pressure [6][7][8].
Under normal circumstances, scleroderma causes inflammation and thickening in your blood vessels. When high-dose systemic steroids are introduced, they can exacerbate this vascular damage and activate the renin-angiotensin-aldosterone system (RAAS)—a hormone system that regulates blood pressure and fluid balance [8][9][10]. This activation can cause your blood vessels to rapidly constrict, choking off the blood supply to your kidneys and triggering a massive spike in blood pressure [8][11].
Warning Signs of SRC
If you ever have to take systemic steroids, or if a crisis occurs naturally, it is vital to know the physical symptoms. A sudden spike in blood pressure and kidney damage can cause:
- Severe, sudden headaches [8][11]
- Blurry or changing vision [8][11]
- Shortness of breath or chest pain [12][13]
- Sudden swelling in your legs or feet, or extreme fatigue [6][8]
While most people with SRC will experience a severe spike in blood pressure, up to 10% of cases are normotensive, meaning the blood pressure stays within a normal range or only rises slightly above the patient’s normal baseline [8][12][11]. Because of this, it is crucial to know your baseline blood pressure so doctors can recognize if it is elevated for you. If SRC does occur, it requires immediate, emergency treatment, usually with a class of blood pressure medications called ACE inhibitors [9][6][14].
The “15 mg Rule” for Corticosteroids
Medical literature consistently identifies moderate-to-high doses of corticosteroids—often defined as 15 mg or more of prednisone per day—as a significant independent risk factor for triggering SRC [15][4][2]. To put this in perspective, a standard “Medrol dose pack” (often given at urgent care) starts at 24 mg on the very first day, placing it well above the danger threshold.
However, there is no single “safe” dose. While the 15 mg/day threshold is a heavily linked tipping point, clinical practice recognizes that any dose of systemic corticosteroids carries a potential risk of triggering or accelerating renal crisis in susceptible patients [2][15]. Therefore, systemic steroids should only be used in systemic sclerosis patients when absolutely necessary (such as for severe life-threatening reactions), and only under the close supervision and careful blood pressure monitoring of a rheumatologist [16][17][18].
Who is at the Highest Risk?
While all systemic sclerosis patients should exercise caution, certain factors put you at an even higher risk for SRC when exposed to corticosteroids:
- Early Diffuse Systemic Sclerosis: Patients who are in the early stages (usually the first 3 to 5 years) of diffuse cutaneous systemic sclerosis are at the highest risk [4][19][20].
- Anti-RNA Polymerase III Antibodies: A blood test can determine your specific antibody profile. If you test positive for anti-RNA polymerase III antibodies, you have a significantly increased risk of developing SRC [21][22][15]. Note: Even patients with the limited cutaneous subtype (formerly known as CREST) are at a higher risk if they carry this specific antibody.
Why You Must Advocate for Yourself
Because systemic sclerosis is a rare disease, many non-specialist doctors—such as those at urgent care clinics, emergency rooms, or general primary care practices—may not be aware of the connection between oral corticosteroids and Scleroderma Renal Crisis [16][23].
Steroid pills are a common, fast-acting “go-to” prescription for reducing inflammation from everyday problems. If a doctor prescribes you a “dose pack” or a burst of prednisone, it is critical that you:
- Stop and Inform: Politely inform the doctor that you have systemic sclerosis and that high-dose corticosteroids are unsafe for your condition because they carry a severe risk of triggering a life-threatening kidney crisis.
- Ask for Alternatives: Ask the doctor if there are non-steroid alternatives to treat your current ailment (such as a topical cream instead of an oral pill for a rash).
- Consult Your Rheumatologist: If the urgent care doctor insists oral steroids are the only option, do not start the medication until you have contacted your rheumatologist for clearance and a monitoring plan.
Wallet Script: Consider carrying a card in your wallet that says: “I have Systemic Sclerosis (Scleroderma). Systemic corticosteroids (oral/IV) carry a severe risk of triggering Scleroderma Renal Crisis. Please consult my rheumatologist before prescribing steroids.”
Common questions in this guide
Can I use topical steroid creams if I have scleroderma?
What are the warning signs of Scleroderma Renal Crisis?
What dose of prednisone is dangerous for scleroderma patients?
Who is at the highest risk for developing Scleroderma Renal Crisis after taking steroids?
What should I do if an urgent care doctor prescribes me a steroid dose pack?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my autoantibody profile, and specifically, do I test positive for anti-RNA polymerase III antibodies?
- 2.Based on my disease subtype (limited vs. diffuse) and antibody profile, how high is my personal risk for developing Scleroderma Renal Crisis?
- 3.What is my baseline blood pressure, and at what number should I seek emergency medical care for a potential renal crisis?
- 4.If I experience a severe allergic reaction or acute respiratory issue on a weekend, what is our agreed-upon, non-steroid emergency plan?
- 5.If an emergency room doctor feels I absolutely must take an oral steroid for a separate emergency, what is the protocol for monitoring my blood pressure and kidneys while on it?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (23)
- 1
Scleroderma Renal Crisis is Associated with High Mortality: A Real-World Study from India.
Dwivedi P, Mb A, Acharya N, et al.
The Journal of the Association of Physicians of India 2021; (69(10)):11-12.
PMID: 34781657 - 2
Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis.
Carroll M, Nagarajah V, Campbell S
BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-253735.
PMID: 36931690 - 3
Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab.
Hanna RM, Abdelnour L, Zuckerman JE, et al.
SAGE open medical case reports 2020; (8()):2050313X20952650 doi:10.1177/2050313X20952650.
PMID: 32913652 - 4
Scleroderma Renal Crisis Complicating Male-to-Female Transgender Hormonal Therapy in a Patient With Long-Standing and Stable Limited Cutaneous Systemic Sclerosis.
Arneson LC, Varga J
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(8S)):S355-S356 doi:10.1097/RHU.0000000000001579.
PMID: 32956156 - 5
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
Shimizu T, Iwamoto N, Okamoto M, et al.
Internal medicine (Tokyo, Japan) 2019; (58(3)):441-445 doi:10.2169/internalmedicine.1441-18.
PMID: 30146597 - 6
Renal Involvement in Systemic Sclerosis: An Update.
Chrabaszcz M, Małyszko J, Sikora M, et al.
Kidney & blood pressure research 2020; (45(4)):532-548 doi:10.1159/000507886.
PMID: 32521536 - 7
Scleroderma renal crisis: observations from the South Australian Scleroderma Register.
Khadra Y, Walker JG, Hakendorf P, et al.
Internal medicine journal 2021; (51(2)):235-242 doi:10.1111/imj.14772.
PMID: 32043674 - 8
Scleroderma Renal Crisis in a Normotensive Patient.
Asamoah-Odei E
Kidney international reports 2016; (1(4)):311-315 doi:10.1016/j.ekir.2016.07.005.
PMID: 29318207 - 9
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L, Varisco PA, Distler O, et al.
Arthritis research & therapy 2020; (22(1)):59 doi:10.1186/s13075-020-2141-2.
PMID: 32209135 - 10
Significance of the angiotensin I/angiotensin II/angiotensin-(1-7) axis in the pathogenesis of systemic sclerosis.
Miziołek B, Bergler-Czop B, Kucharz E, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(3)):558-564 doi:10.1111/jdv.16103.
PMID: 31746507 - 11
Scleroderma renal crisis: a review for emergency physicians.
Montrief T, Koyfman A, Long B
Internal and emergency medicine 2019; (14(4)):561-570 doi:10.1007/s11739-019-02096-2.
PMID: 31076978 - 12
Diffuse Cutaneous Systemic Sclerosis With Normotensive Scleroderma Renal Crisis and Myopericarditis: A Case Report.
Barbosa Franco Zörrer LA, Yugi de Souza Terui L, Fanini Balena R, et al.
Cureus 2025; (17(2)):e78858 doi:10.7759/cureus.78858.
PMID: 40084306 - 13
An Acute Large Pericardial Effusion in a Scleroderma Renal Crisis.
Ghallab M, Abosheaishaa H, Haseeb Ul Rasool M, et al.
Cureus 2023; (15(7)):e41897 doi:10.7759/cureus.41897.
PMID: 37581132 - 14
Kidney Involvement in Systemic Sclerosis.
Reggiani F, Moroni G, Ponticelli C
Journal of personalized medicine 2022; (12(7)) doi:10.3390/jpm12071123.
PMID: 35887620 - 15
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
Moinzadeh P, Kuhr K, Siegert E, et al.
The Journal of rheumatology 2020; (47(2)):241-248 doi:10.3899/jrheum.180582.
PMID: 30936287 - 16
Thrombotic Microangiopathy and Multiple Organ Failure in Scleroderma Renal Crisis: A Case Report.
Aterini L, Gallo M, Vadalà B, Aterini S
Cureus 2023; (15(8)):e44322 doi:10.7759/cureus.44322.
PMID: 37779794 - 17
Spectrum of renal disease in scleroderma other than scleroderma renal crisis: A review of the literature.
Farrukh L, Steen V, Shapiro L, et al.
Clinical nephrology 2024; (102(2)):97-106 doi:10.5414/CN111243.
PMID: 38699985 - 18
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS).
Herrick AL, Griffiths-Jones DJ, Ryder WD, et al.
Journal of scleroderma and related disorders 2021; (6(2)):146-153 doi:10.1177/2397198320957552.
PMID: 34222671 - 19
Systemic sclerosis - the dermatological perspective.
Sticherling M
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2019; (17(7)):716-728 doi:10.1111/ddg.13887.
PMID: 31364293 - 20
Systemic sclerosis with renal crisis and pericardial effusion.
Prudhvi K, Jonnadula J, Kutti Sridharan G, Dominguez M
Clinical case reports 2020; (8(12)):3656-3657 doi:10.1002/ccr3.3467.
PMID: 33364023 - 21
Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
Takada D, Hoshino J, Kikuchi K, et al.
Modern rheumatology 2018; (28(2)):369-372 doi:10.3109/14397595.2015.1112873.
PMID: 26942857 - 22
A Unique Presentation of Anti-RNA Polymerase III Positive Systemic Sclerosis Sine Scleroderma.
Lee CM, Girnita D, Sharma A, et al.
Case reports in rheumatology 2016; (2016()):8536341 doi:10.1155/2016/8536341.
PMID: 27559487 - 23
Prediction of prognosis in patients with systemic sclerosis based on a machine-learning model.
Zheng Y, Jin W, Zheng Z, et al.
Clinical rheumatology 2024; (43(8)):2573-2584 doi:10.1007/s10067-024-07039-7.
PMID: 38937388
This page provides educational information about the risks of corticosteroids in scleroderma. Always consult your rheumatologist before starting or stopping any medications or treatments.
Get notified when new evidence is published on Scleroderma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.